Tapewire

Nasdaq · USD

TYRA

Tyra Biosciences, Inc.

Export transactions ↓
Tapewire entity
4680
SEC CIK
0001863127
Parsed reports
203

Last 12 months

Inside the activity.

1 purchase rows · 14 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202507
Dec 202502
Jan 202602
Feb 202602
Mar 202601
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202610
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 27, 2024 Filed Feb 29, 2024 23:58 UTC
Bensen DanielChief Operating Officer
SaleCommon Stock 745 $20.00 $14,900.00
Disclosure

SEC source: 0000950170-24-023406 · ownership.xml · nonDerivative · entry 1

Bensen Daniel · CIK 0001880946 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 450,735

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022.

Read SEC document
February 12, 2024 Filed Feb 15, 2024 02:00 UTC
Bensen DanielChief Operating Officer
SaleCommon Stock 1,501 $20.00 $30,020.00
Disclosure

SEC source: 0000950170-24-015559 · ownership.xml · nonDerivative · entry 1

Bensen Daniel · CIK 0001880946 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 451,480

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022.

Read SEC document
February 07, 2024 Filed Feb 10, 2024 00:26 UTC
Bensen DanielChief Operating Officer
SaleCommon Stock 9,587 $18.09 $173,466.22
Disclosure

SEC source: 0000950170-24-013474 · ownership.xml · nonDerivative · entry 1

Bensen Daniel · CIK 0001880946 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 452,981

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022.

F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $18.00 to $18.48. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Read SEC document
February 06, 2024 Filed Feb 7, 2024 01:23 UTC
Bensen DanielChief Operating Officer
SaleCommon Stock 15,413 $18.09 $278,827.34
Disclosure

SEC source: 0000950170-24-011880 · ownership.xml · nonDerivative · entry 4

Bensen Daniel · CIK 0001880946 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 462,568

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022.

F4 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $18.00 to $18.44. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Read SEC document
February 06, 2024 Filed Feb 8, 2024 17:09 UTC
LEWIS JOSEPHSee Remarks
Davis Aaron I.See Remarks
GrantWarrant (right to purchase) · Derivative 705,280 $13.01 Strike: $0.00 $9,174,987.52
Disclosure

SEC source: 0000895345-24-000035 · form4.xml · derivative · entry 3

Boxer Capital, LLC · CIK 0001465837 · See Remarks

Boxer Asset Management Inc. · CIK 0001465836 · See Remarks

LEWIS JOSEPH · CIK 0001015747 · See Remarks

MVA Investors, LLC · CIK 0001468223 · See Remarks

Davis Aaron I. · CIK 0001465914 · See Remarks

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 705,280

Underlying: Common Stock · 705,280 shares

Expires not disclosed

F3 · derivative.exercise_date: These Warrants are exercisable immediately (subject to any applicable beneficial ownership limitation) and do not have an expiration date.

F3 · derivative.expiration_date: These Warrants are exercisable immediately (subject to any applicable beneficial ownership limitation) and do not have an expiration date.

F2 · ownership.direct: These securities are owned directly by Boxer Capital, LLC ("Boxer Capital"). Boxer Asset Management Inc. ("Boxer Management") is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Management. Mr. Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any.

Read SEC document
February 06, 2024 Filed Feb 8, 2024 17:09 UTC
LEWIS JOSEPHSee Remarks
Davis Aaron I.See Remarks
GrantCommon Stock 63,412 $13.01 $824,990.12
Disclosure

SEC source: 0000895345-24-000035 · form4.xml · nonDerivative · entry 1

Boxer Capital, LLC · CIK 0001465837 · See Remarks

Boxer Asset Management Inc. · CIK 0001465836 · See Remarks

LEWIS JOSEPH · CIK 0001015747 · See Remarks

MVA Investors, LLC · CIK 0001468223 · See Remarks

Davis Aaron I. · CIK 0001465914 · See Remarks

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 85,939

F1 · ownership.nature: These securities are owned directly by MVA Investors, LLC ("MVA Investors"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any.

Read SEC document
February 06, 2024 Filed Feb 8, 2024 22:16 UTC
RA CAPITAL MANAGEMENT, L.P.Director · 10% owner
RA Capital Healthcare Fund LPDirector · 10% owner
RA Capital Nexus Fund, L.P.Director · 10% owner
Kolchinsky PeterDirector · 10% owner
Shah Rajeev M.Director · 10% owner
GrantPre-Funded Warrants (Right to Buy) · Derivative 1,538,457 $13.01 Strike: $0.00 $20,013,787.11
Disclosure

SEC source: 0001415889-24-003043 · form4-02082024_100255.xml · derivative · entry 4

RA CAPITAL MANAGEMENT, L.P. · CIK 0001346824 · Director · 10% owner

RA Capital Healthcare Fund LP · CIK 0001315082 · Director · 10% owner

RA Capital Nexus Fund, L.P. · CIK 0001780117 · Director · 10% owner

Kolchinsky Peter · CIK 0001384859 · Director · 10% owner

Shah Rajeev M. · CIK 0001619841 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnotes

Disclosed balance after: 1,538,457

Underlying: Common Stock · 1,538,457 shares

Expires not disclosed

F5 · derivative.exercise_date: The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 19.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise.

F5 · derivative.expiration_date: The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 19.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise.

F1 · ownership.nature: These securities are held directly by RA Capital Healthcare Fund, L.P. (the "Fund").

F2 · ownership.nature: RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund, RA Capital Nexus Fund, L.P. (the "Nexus Fund"), and a separately managed account (the "Account"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.

Read SEC document
February 06, 2024 Filed Feb 8, 2024 22:16 UTC
RA CAPITAL MANAGEMENT, L.P.Director · 10% owner
RA Capital Healthcare Fund LPDirector · 10% owner
RA Capital Nexus Fund, L.P.Director · 10% owner
Kolchinsky PeterDirector · 10% owner
Shah Rajeev M.Director · 10% owner
GrantCommon Stock 3,180,155 $13.01 $41,373,816.55
Disclosure

SEC source: 0001415889-24-003043 · form4-02082024_100255.xml · nonDerivative · entry 1

RA CAPITAL MANAGEMENT, L.P. · CIK 0001346824 · Director · 10% owner

RA Capital Healthcare Fund LP · CIK 0001315082 · Director · 10% owner

RA Capital Nexus Fund, L.P. · CIK 0001780117 · Director · 10% owner

Kolchinsky Peter · CIK 0001384859 · Director · 10% owner

Shah Rajeev M. · CIK 0001619841 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnotes

Disclosed balance after: 8,477,275

F1 · ownership.nature: These securities are held directly by RA Capital Healthcare Fund, L.P. (the "Fund").

F2 · ownership.nature: RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund, RA Capital Nexus Fund, L.P. (the "Nexus Fund"), and a separately managed account (the "Account"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.

Read SEC document
February 05, 2024 Filed Feb 7, 2024 01:22 UTC
Harris ToddDirector · President and CEO
SaleCommon Stock 13,817 $16.97 $234,430.28
Disclosure

SEC source: 0000950170-24-011879 · ownership.xml · nonDerivative · entry 3

Harris Todd · CIK 0001711463 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,502,697

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022.

F4 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.51 to $17.32. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Read SEC document
February 02, 2024 Filed Feb 7, 2024 01:23 UTC
Bensen DanielChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 25,393 $0.00 Strike: $0.61 $0.00
Disclosure

SEC source: 0000950170-24-011880 · ownership.xml · derivative · entry 5

Bensen Daniel · CIK 0001880946 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 108,110

Underlying: Common Stock · 25,393 shares

Expires 2030-01-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter.

Read SEC document
February 02, 2024 Filed Feb 7, 2024 01:23 UTC
Bensen DanielChief Operating Officer
SaleCommon Stock 2,300 $17.04 $39,198.90
Disclosure

SEC source: 0000950170-24-011880 · ownership.xml · nonDerivative · entry 3

Bensen Daniel · CIK 0001880946 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 477,981

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022.

F3 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $17.00 to $17.17. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Read SEC document
February 02, 2024 Filed Feb 7, 2024 01:23 UTC
Bensen DanielChief Operating Officer
SaleCommon Stock 73,093 $16.31 $1,191,898.31
Disclosure

SEC source: 0000950170-24-011880 · ownership.xml · nonDerivative · entry 2

Bensen Daniel · CIK 0001880946 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 480,281

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022.

F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.91. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Read SEC document
February 02, 2024 Filed Feb 7, 2024 01:23 UTC
Bensen DanielChief Operating Officer
Exercise / conversionCommon Stock 25,393 $0.61 $15,489.73
Disclosure

SEC source: 0000950170-24-011880 · ownership.xml · nonDerivative · entry 1

Bensen Daniel · CIK 0001880946 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 553,374

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 02, 2024 Filed Feb 7, 2024 01:22 UTC
Harris ToddDirector · President and CEO
SaleCommon Stock 7,187 $17.04 $122,494.51
Disclosure

SEC source: 0000950170-24-011879 · ownership.xml · nonDerivative · entry 2

Harris Todd · CIK 0001711463 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,516,514

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022.

F3 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $17.00 to $17.16. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Read SEC document
February 02, 2024 Filed Feb 7, 2024 01:22 UTC
Harris ToddDirector · President and CEO
SaleCommon Stock 78,996 $16.45 $1,299,160.32
Disclosure

SEC source: 0000950170-24-011879 · ownership.xml · nonDerivative · entry 1

Harris Todd · CIK 0001711463 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,523,701

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022.

F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.9995. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Read SEC document
September 15, 2023 Filed Sep 19, 2023 23:37 UTC
Tada HiroomiChief Medical Officer
GrantCommon Stock 1,337 $6.58 $8,796.12
Disclosure

SEC source: 0001209191-23-050094 · doc4.xml · nonDerivative · entry 1

Tada Hiroomi · CIK 0001880593 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,467

F1 · kind: These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan.

Read SEC document
September 15, 2023 Filed Sep 19, 2023 23:36 UTC
Harris ToddDirector · President and CEO
GrantCommon Stock 1,421 $6.58 $9,348.76
Disclosure

SEC source: 0001209191-23-050092 · doc4.xml · nonDerivative · entry 1

Harris Todd · CIK 0001711463 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,602,697

F1 · kind: These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan.

Read SEC document
September 15, 2023 Filed Sep 19, 2023 23:27 UTC
Fuhrman AlanChief Financial Officer
GrantCommon Stock 1,463 $12.50 $18,292.62
Disclosure

SEC source: 0001209191-23-050090 · doc4.xml · nonDerivative · entry 1

Fuhrman Alan · CIK 0001303521 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,463

F1 · kind: These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan.

Read SEC document
July 28, 2023 Filed Aug 1, 2023 21:41 UTC
Tada HiroomiChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 115,000 $0.00 Strike: $14.35 $0.00
Disclosure

SEC source: 0001209191-23-044047 · doc4.xml · derivative · entry 1

Tada Hiroomi · CIK 0001880593 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115,000

Underlying: Common Stock · 115,000 shares

Expires 2033-07-27

F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly following July 28, 2023, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.

Read SEC document
July 28, 2023 Filed Aug 1, 2023 21:38 UTC
Harris ToddDirector · President and CEO
GrantStock Option (Right to Buy) · Derivative 330,000 $0.00 Strike: $14.35 $0.00
Disclosure

SEC source: 0001209191-23-044044 · doc4.xml · derivative · entry 1

Harris Todd · CIK 0001711463 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 330,000

Underlying: Common Stock · 330,000 shares

Expires 2033-07-27

F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly following July 28, 2023, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.

Read SEC document
July 28, 2023 Filed Aug 1, 2023 21:34 UTC
Fuhrman AlanChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 62,685 $0.00 Strike: $14.35 $0.00
Disclosure

SEC source: 0001209191-23-044035 · doc4.xml · derivative · entry 1

Fuhrman Alan · CIK 0001303521 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,685

Underlying: Common Stock · 62,685 shares

Expires 2033-07-27

F1 · derivative.exercise_date: 25% of the shares subject to the option will vest on July 28, 2024, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date.

Read SEC document
July 28, 2023 Filed Aug 1, 2023 21:30 UTC
Bensen DanielChief Operating Officer
GrantStock Option (Right to Buy) · Derivative 110,000 $0.00 Strike: $14.35 $0.00
Disclosure

SEC source: 0001209191-23-044027 · doc4.xml · derivative · entry 1

Bensen Daniel · CIK 0001880946 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,000

Underlying: Common Stock · 110,000 shares

Expires 2033-07-27

F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly following July 28, 2023, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.

Read SEC document
July 21, 2023 Filed Jul 22, 2023 00:52 UTC
Bensen DanielChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 3,900 $0.00 Strike: $0.61 $0.00
Disclosure

SEC source: 0001209191-23-043165 · doc4.xml · derivative · entry 6

Bensen Daniel · CIK 0001880946 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 133,503

Underlying: Common Stock · 3,900 shares

Expires 2030-01-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter.

Read SEC document
July 21, 2023 Filed Jul 22, 2023 00:52 UTC
Bensen DanielChief Operating Officer
SaleCommon Stock 3,900 $16.01 $62,427.69
Disclosure

SEC source: 0001209191-23-043165 · doc4.xml · nonDerivative · entry 4

Bensen Daniel · CIK 0001880946 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 527,981

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022.

F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.07. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Read SEC document
July 21, 2023 Filed Jul 22, 2023 00:52 UTC
Bensen DanielChief Operating Officer
Exercise / conversionCommon Stock 3,900 $0.61 $2,379.00
Disclosure

SEC source: 0001209191-23-043165 · doc4.xml · nonDerivative · entry 3

Bensen Daniel · CIK 0001880946 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 531,881

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 19, 2023 Filed Jul 22, 2023 00:52 UTC
Bensen DanielChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 207 $0.00 Strike: $0.61 $0.00
Disclosure

SEC source: 0001209191-23-043165 · doc4.xml · derivative · entry 5

Bensen Daniel · CIK 0001880946 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 137,403

Underlying: Common Stock · 207 shares

Expires 2030-01-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter.

Read SEC document
July 19, 2023 Filed Jul 22, 2023 00:52 UTC
Bensen DanielChief Operating Officer
SaleCommon Stock 207 $16.08 $3,327.53
Disclosure

SEC source: 0001209191-23-043165 · doc4.xml · nonDerivative · entry 2

Bensen Daniel · CIK 0001880946 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 527,981

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022.

Read SEC document
July 19, 2023 Filed Jul 22, 2023 00:52 UTC
Bensen DanielChief Operating Officer
Exercise / conversionCommon Stock 207 $0.61 $126.27
Disclosure

SEC source: 0001209191-23-043165 · doc4.xml · nonDerivative · entry 1

Bensen Daniel · CIK 0001880946 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 528,188

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 17, 2023 Filed Jul 17, 2023 23:35 UTC
Bensen DanielChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 1,900 $0.00 Strike: $0.61 $0.00
Disclosure

SEC source: 0001209191-23-042495 · doc4.xml · derivative · entry 6

Bensen Daniel · CIK 0001880946 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 137,610

Underlying: Common Stock · 1,900 shares

Expires 2030-01-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter.

Read SEC document
July 17, 2023 Filed Jul 17, 2023 23:35 UTC
Bensen DanielChief Operating Officer
SaleCommon Stock 1,900 $16.03 $30,464.03
Disclosure

SEC source: 0001209191-23-042495 · doc4.xml · nonDerivative · entry 4

Bensen Daniel · CIK 0001880946 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 527,981

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022.

F3 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.10. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Read SEC document
July 17, 2023 Filed Jul 17, 2023 23:35 UTC
Bensen DanielChief Operating Officer
Exercise / conversionCommon Stock 1,900 $0.61 $1,159.00
Disclosure

SEC source: 0001209191-23-042495 · doc4.xml · nonDerivative · entry 3

Bensen Daniel · CIK 0001880946 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 529,881

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 13, 2023 Filed Jul 17, 2023 23:35 UTC
Bensen DanielChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 500 $0.00 Strike: $0.61 $0.00
Disclosure

SEC source: 0001209191-23-042495 · doc4.xml · derivative · entry 5

Bensen Daniel · CIK 0001880946 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 139,510

Underlying: Common Stock · 500 shares

Expires 2030-01-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter.

Read SEC document
July 13, 2023 Filed Jul 17, 2023 23:35 UTC
Bensen DanielChief Operating Officer
SaleCommon Stock 500 $16.13 $8,065.00
Disclosure

SEC source: 0001209191-23-042495 · doc4.xml · nonDerivative · entry 2

Bensen Daniel · CIK 0001880946 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 527,981

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022.

F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.05 and $16.25. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Read SEC document
July 13, 2023 Filed Jul 17, 2023 23:35 UTC
Bensen DanielChief Operating Officer
Exercise / conversionCommon Stock 500 $0.61 $305.00
Disclosure

SEC source: 0001209191-23-042495 · doc4.xml · nonDerivative · entry 1

Bensen Daniel · CIK 0001880946 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 528,481

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 12, 2023 Filed Jul 12, 2023 22:41 UTC
Bensen DanielChief Operating Officer
SaleCommon Stock 201 $16.23 $3,262.31
Disclosure

SEC source: 0001209191-23-042114 · doc4.xml · nonDerivative · entry 6

Bensen Daniel · CIK 0001880946 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 527,981

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022.

F4 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.07 to $16.39. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Read SEC document
July 12, 2023 Filed Jul 12, 2023 22:41 UTC
Bensen DanielChief Operating Officer
Exercise / conversionCommon Stock 201 $0.61 $122.61
Disclosure

SEC source: 0001209191-23-042114 · doc4.xml · nonDerivative · entry 5

Bensen Daniel · CIK 0001880946 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 528,182

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 11, 2023 Filed Jul 12, 2023 22:41 UTC
Bensen DanielChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 201 $0.00 Strike: $0.61 $0.00
Disclosure

SEC source: 0001209191-23-042114 · doc4.xml · derivative · entry 9

Bensen Daniel · CIK 0001880946 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 140,010

Underlying: Common Stock · 201 shares

Expires 2030-01-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter.

Read SEC document
July 11, 2023 Filed Jul 12, 2023 22:41 UTC
Bensen DanielChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 500 $0.00 Strike: $0.61 $0.00
Disclosure

SEC source: 0001209191-23-042114 · doc4.xml · derivative · entry 8

Bensen Daniel · CIK 0001880946 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 140,211

Underlying: Common Stock · 500 shares

Expires 2030-01-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter.

Read SEC document
July 11, 2023 Filed Jul 12, 2023 22:41 UTC
Bensen DanielChief Operating Officer
SaleCommon Stock 500 $16.02 $8,009.50
Disclosure

SEC source: 0001209191-23-042114 · doc4.xml · nonDerivative · entry 4

Bensen Daniel · CIK 0001880946 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 527,981

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022.

F3 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.06. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Read SEC document
July 11, 2023 Filed Jul 12, 2023 22:41 UTC
Bensen DanielChief Operating Officer
Exercise / conversionCommon Stock 500 $0.61 $305.00
Disclosure

SEC source: 0001209191-23-042114 · doc4.xml · nonDerivative · entry 3

Bensen Daniel · CIK 0001880946 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 528,481

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 10, 2023 Filed Jul 12, 2023 22:41 UTC
Bensen DanielChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 1,202 $0.00 Strike: $0.61 $0.00
Disclosure

SEC source: 0001209191-23-042114 · doc4.xml · derivative · entry 7

Bensen Daniel · CIK 0001880946 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 140,711

Underlying: Common Stock · 1,202 shares

Expires 2030-01-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter.

Read SEC document
July 10, 2023 Filed Jul 12, 2023 22:41 UTC
Bensen DanielChief Operating Officer
SaleCommon Stock 1,202 $16.01 $19,240.29
Disclosure

SEC source: 0001209191-23-042114 · doc4.xml · nonDerivative · entry 2

Bensen Daniel · CIK 0001880946 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 527,981

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022.

F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.12. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Read SEC document
July 10, 2023 Filed Jul 12, 2023 22:41 UTC
Bensen DanielChief Operating Officer
Exercise / conversionCommon Stock 1,202 $0.61 $733.22
Disclosure

SEC source: 0001209191-23-042114 · doc4.xml · nonDerivative · entry 1

Bensen Daniel · CIK 0001880946 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 529,183

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 03, 2023 Filed Jul 3, 2023 21:31 UTC
Bensen DanielChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 4,265 $0.00 Strike: $0.61 $0.00
Disclosure

SEC source: 0001209191-23-040654 · doc4.xml · derivative · entry 10

Bensen Daniel · CIK 0001880946 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 141,913

Underlying: Common Stock · 4,265 shares

Expires 2030-01-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter.

Read SEC document
July 03, 2023 Filed Jul 3, 2023 21:31 UTC
Bensen DanielChief Operating Officer
SaleCommon Stock 400 $17.04 $6,814.00
Disclosure

SEC source: 0001209191-23-040654 · doc4.xml · nonDerivative · entry 7

Bensen Daniel · CIK 0001880946 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 527,981

F5 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $17.02 to $17.05. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Read SEC document
July 03, 2023 Filed Jul 3, 2023 21:31 UTC
Bensen DanielChief Operating Officer
SaleCommon Stock 3,865 $16.30 $62,999.89
Disclosure

SEC source: 0001209191-23-040654 · doc4.xml · nonDerivative · entry 6

Bensen Daniel · CIK 0001880946 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 528,381

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022.

F4 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16 to $17. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Read SEC document
July 03, 2023 Filed Jul 3, 2023 21:31 UTC
Bensen DanielChief Operating Officer
Exercise / conversionCommon Stock 4,265 $0.61 $2,601.65
Disclosure

SEC source: 0001209191-23-040654 · doc4.xml · nonDerivative · entry 5

Bensen Daniel · CIK 0001880946 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 532,246

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 30, 2023 Filed Jul 3, 2023 21:31 UTC
Bensen DanielChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 18,819 $0.00 Strike: $0.61 $0.00
Disclosure

SEC source: 0001209191-23-040654 · doc4.xml · derivative · entry 9

Bensen Daniel · CIK 0001880946 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 146,178

Underlying: Common Stock · 18,819 shares

Expires 2030-01-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter.

Read SEC document
June 30, 2023 Filed Jul 3, 2023 21:31 UTC
Bensen DanielChief Operating Officer
SaleCommon Stock 18,819 $16.97 $319,418.65
Disclosure

SEC source: 0001209191-23-040654 · doc4.xml · nonDerivative · entry 4

Bensen Daniel · CIK 0001880946 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 527,981

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022.

F3 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.45 to $17.14. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Read SEC document
June 30, 2023 Filed Jul 3, 2023 21:31 UTC
Bensen DanielChief Operating Officer
Exercise / conversionCommon Stock 18,819 $0.61 $11,479.59
Disclosure

SEC source: 0001209191-23-040654 · doc4.xml · nonDerivative · entry 3

Bensen Daniel · CIK 0001880946 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 546,800

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.